Segment Data (Tables)

3 Months Ended

Dec. 31, 2016

Segment Reporting [Abstract]

Financial Information for Company's Segments

Financial information for the Company’s segments was as follows:

	Three Months Ended December 31,
(Millions of dollars)	2016			2015
Revenues (A)
Medical	$	1,964		$	2,054
Life Sciences	958			933
Total Revenues	$	2,922		$	2,986
Income Before Income Taxes
Medical	$	548		$	465
Life Sciences	198			202
Total Segment Operating Income	747			667
Acquisitions and other restructurings	(87		)	(121		)
Net interest expense	(89		)	(91		)
Other unallocated items (B)	121			(189		)
Income Before Income Taxes	$	692		$	266

(A) Intersegment revenues are not material.

(B) Primarily comprised of foreign exchange, corporate expenses, and share-based compensation expense. The amount for the three months ended December 31, 2016 also included a $336 million reversal of certain reserves related to an appellate court decision which, among other things, reversed an unfavorable antitrust judgment in the RTI case. Additional disclosures regarding this legal matter are provided Note 5.

Revenues by Geographic Areas

Revenues by geographic areas were as follows:

	Three Months Ended December 31,
(Millions of dollars)	2016		2015
Revenues
United States	$	1,630	$	1,691
International	1,292		1,295
Total Revenues	$	2,922	$	2,986